BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, May 6, 2026
Home » Authors » John Brosky

John Brosky

Articles

ARTICLES

EuropCR 2015 Interview, Part II: Philips-Volcano combo combo to clear competitors in cath lab

May 26, 2015
By John Brosky

EuroPCR Interview, Part 1: Acquiring Volcano brings Philips 'intimacy' in $4 billion market

May 22, 2015
By John Brosky
PARIS — After selling its lighting division, Royal Philips (Amsterdam, the Netherlands) made a strategic decision to expand its healthcare division as a stand-alone business. In December 2014, Philips announced it would pay $1.2 billion to acquire Volcano Corporation (San Diego), a leader in the fast-growing interventional cardiology segment.
Read More

EuroPCR notebook: Edwards pauses enrollment in FORTIS mitral valve program

May 21, 2015
By John Brosky

Renal Denervation Resurrected: After clinical setbacks, renal denervation reboots with clinicians taking the lead

May 21, 2015
By John Brosky
PARIS — The launch of renal denervation for the control of resistant hypertension is destine to become a textbook case study in how not to market a medical device.
Read More

EuroPCR 2015: Looking beyond cardiology, heart 'operators' eye stroke intervention

May 20, 2015
By John Brosky
PARIS — Calling all interventional cardiologists. Your skills are needed in brain surgery. Stat! Stopping short of a general alarm, the EuroPCR (Paris Course on Revascularization; Paris) organization has formally issued a call to action to mobilize its growing army of interventional cardiologists to help organize stroke intervention centers.
Read More

Report from Europe: Northern Europe best entry point for mobile health apps

May 18, 2015
By John Brosky

MDD Interview: NextStim targets $1.8B with brain stimulation for stroke therapy

May 13, 2015
By John Brosky

Report from Europe: Carmat's 2nd patient dies due to artificial heart dysfunction

May 11, 2015
By John Brosky
PARIS — The second patient to receive a fully implantable artificial heart made by Carmat (Paris) died May 2, after a rescue operation at the University Hospital Center (Nantes, France) aimed at replacing a malfunctioning heart that had kept him alive for nine months (Medical Device Daily, May 7, 2015).
Read More

IVD evidence a key to compliance with revised CE mark rules

April 17, 2015
By John Brosky

Report from Europe: Latvia forces breakout of CE mark reform from Council stalemate

April 16, 2015
By John Brosky
View All Articles by John Brosky

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 5, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • Auvelity

    Axsome’s Auvelity cleared for large Alzheimer’s agitation market

    BioWorld
    Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
  • Strategy compass

    Bio Korea 2026: US policy risks shift to execution framework

    BioWorld
    Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
  • Pancreas

    Sonire starts US study of cancer HIFU after $18M series A

    BioWorld
    Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing